Abstract Library

#2794 Pancreatic Neuroendocrine Tumor (pNET) Showing Remission after Tuberculostatic Treatment – An Unusual Case Report Suggesting Anti-Proliferative Effects of Antibiotics in pNETs

Introduction: Several classes of antibiotics have been associated with anti-proliferative effects on cancer cells; however, there is no data on this regarding pNETs.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Kiesewetter B

Authors: Kiesewetter B, Lagler H, Mazal P, Kretschmer-Chott E, Haug A,

Keywords: pancreatic neuroendocrine tumors, treatment, somatostatin analogs, antibiotics, lanreotide,

#1667 A Qualitative Exploration into the Experience of Neuroendocrine Pancreatic Cancer Patients Receiving Molecular Targeted Therapies

Introduction: Despite extensive efficacy date and limited data examining drug related side effects, the patient experience and quality of life data is limited for this patient group

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Quaglia E

Authors: Quaglia E, Uzzell M, Woodcock J, Caplin M,

Keywords: Sunitinib, everolimus,

#1376 Pancreatic Neuroendocrine Tumors: Experience of a Tertiary Care Center

Introduction: Pancreatic neuroendocrine tumors (PNET) are rare functionally and biologically heterogeneous tumors accounting for less than 5% of pancreatic cancer

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Assi R

Authors: Assi R, Hakim A, Mukherji D, Abdel-Massih S, Charafeddine M,

Keywords: PNET stage IV surgery ki67,

#847 Incidental Pathological Finding of Pancreatic Non-Functioning Neuroendocrine Tumors

Introduction: Little is known about the incidental finding of non-functioning NETs (Neuroendocrine Tumors) during pancreatic surgery performed for other reasons or during pathological examination of the surgical sample.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Milanetto A, Liço V, Moletta L, Bettini E, Alaggio R,

Keywords: neuroendocrine tumors, pancreatic cancer, incidental tumor,

#814 Chromogranin A is a Useful Marker in Japanese Patients with Pancreatic Neuroendocrine Tumors

Introduction: Although Chromogranin A (CgA) is known as a useful marker for pancreatic neuroendocrine tumors (pNET) in the West, the usefulness of CgA in Japanese patients with pNETs is unclear.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Hijioka M, Ito T, Igarashi H, Ueda K, Fujiyama T,

Keywords: chromogranin A, pNET, Japanese,